Description
BRONHOTON Pharmacodynamics
BRONHOTON is a combination drug of plant origin, has anti-cough and bronchodilator effects.
Glaucine suppresses the cough center without, however, leading to respiratory depression, development of constipation and drug dependence.
Ephedrine stimulates the respiratory center, dilates the bronchi and (due to a vasoconstrictor effect) eliminates edema of the bronchial mucosa.
Basil oil has a sedative (mild), antimicrobial and antispasmodic effect.
Indications
The complex treatment of diseases of the respiratory system, accompanied by a dry cough: acute and chronic bronchitis, tracheobronchitis, bronchial asthma, whooping cough.
Contraindications .
Hypersensitivity to the components of the drug.
Sucrose/isamaltase deficiency, fructose intolerance, glucose-galactose malabsorption (due to the sucrose content of the drug).
Coronary heart disease, arterial hypertension, heart failure, arrhythmias, coronary atherosclerosis, pheochromocytoma, thyrotoxicosis, closed-angle glaucoma, diabetes mellitus, hyperthyroidism, prostatic hyperplasia, insomnia, pregnancy, breast-feeding period, children under 3 years, upcoming general anesthesia with cyclopropane or haloton.
Caution:
Patients prone to the development of drug addiction; patients with liver disease, alcoholism, epilepsy, brain disease, craniocerebral trauma; children.
Dosage and administration
- Adults – 1 tablespoon 3-4 times a day.
- Children from 3 to 10 years – 1 teaspoon 3 times a day.
- Children over 10 years – 2 teaspoons 3 times a day.
- The duration of treatment is 5-7 days.
